2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Writing Committee Members*;
Bernard J. Gersh, MB, ChB, DPhil, FACC, FAHA, Co-Chair*†;
Barry J. Maron, MD, FACC, Co-Chair*†;
Robert O. Bonow, MD, MACC, FAHA‡;
Joseph A. Dearani, MD, FACC§‖;
Michael A. Fifer, MD, FACC, FAHA*†;
Mark S. Link, MD, FACC, FHRS*¶;
Srihari S. Naidu, MD, FACC, FSCAI*#;
Rick A. Nishimura, MD, FACC, FAHA†;
Steve R. Ommen, MD, FACC, FAHA†;
Harry Rakowski, MD, FACC, FASE†**;
Christine E. Seidman, MD, FAHA†;
Jeffrey A. Towbin, MD, FACC, FAHA††;
James E. Udelson, MD, FACC, FASNC‡‡§§;
Clyde W. Yancy, MD, FACC, FAHA‖‖

+ Author Affiliations

^*Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for detailed information.
^†ACCF/AHA Representative.
^‡ACCF/AHA Task Force on Performance Measures Liaison.
^§Society of Thoracic Surgeons Representative.
^‖American Association for Thoracic Surgery Representative.
^¶Heart Rhythm Society Representative.
^#Society for Cardiovascular Angiography and Interventions Representative.
^**American Society of Echocardiography Representative.
^††Pediatric Content Expert.
^‡‡Heart Failure Society of America Representative.
^§§American Society of Nuclear Cardiology Representative.
^‖‖ACCF/AHA Task Force on Practice Guidelines Liaison.
^¶¶Former Task Force member during this writing effort.

Key Words:

Table of Contents

Preamble . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e785
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e787
  - 1.1. Methodology and Evidence Review . . . . . . . . . .e787
  - 1.2. Organization of the Writing Committee . . . . . . .e787
  - 1.3. Document Review and Approval. . . . . . . . . . . . .e787
  - 1.4. Scope of the Guideline . . . . . . . . . . . . . . . . . . . .e788
2. Prevalence/Nomenclature/Differential Diagnosis . . . .e788
  - 2.1. Prevalence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e788
  - 2.2. Nomenclature . . . . . . . . . . . . . . . . . . . . . . . . . . .e788
    - 2.2.1. Historical Context. . . . . . . . . . . . . . . . . . .e788
    - 2.2.2. Clinical Definition and Differential Diagnosis . . . . . . . . . . . . . . . . . . …

[Full Text of this Article]

Articles citing this article

Experience, outcomes and impact of delayed indication for video-assisted wide septal myectomy in 69 consecutive patients with hypertrophic cardiomyopathy Eur J Cardiothorac Surg. 2013;0:ezt050v1-ezt050,
- Abstract
- Full Text
- PDF
Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy >=60 Years of Age Circulation. 2013;127:585-593,
- Abstract
- Full Text
- PDF
Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome Europace. 2013;0:eus408v1-eus408,
- Abstract
- Full Text
- PDF
A Clinical Approach to Inherited Hypertrophy: The Use of Family History in Diagnosis, Risk Assessment, and Management Circ Cardiovasc Genet. 2013;6:118-131,
- Full Text
- PDF
Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy Circ Cardiovasc Genet. 2013;6:19-26,
- Abstract
- Full Text
- PDF
Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy Br. J. Sports. Med.. 2013;47:137-152,
- Abstract
- Full Text
- PDF
Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents: A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing Circulation. 2013;127:48-54,
- Abstract
- Full Text
- PDF
Role of Mitral Valve Plication in the Surgical Management of Hypertrophic Cardiomyopathy Ann. Thorac. Surg.. 2012;94:1990-1998,
- Abstract
- Full Text
- PDF
The Safety of Cardiopulmonary Exercise Testing in a Population With High-Risk Cardiovascular Diseases Circulation. 2012;126:2465-2472,
- Abstract
- Full Text
- PDF
Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum Br. J. Sports. Med.. 2012;46:i51-i58,
- Abstract
- Full Text
- PDF
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families: A Scientific Statement From the American Heart Association Circulation. 2012;126:2146-2172,
- Abstract
- Full Text
- PDF
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation. 2012;126:1784-1800,
- Full Text
- PDF
Evolution of Hypertrophic Cardiomyopathy to a Contemporary Treatable Disease Circulation. 2012;126:1640-1644,
- Full Text
- PDF
Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy: Systematic Review and Meta-Analysis Circ Heart Fail. 2012;5:552-559,
- Abstract
- Full Text
- PDF
Population-Based Variation in Cardiomyopathy Genes Circ Cardiovasc Genet. 2012;5:391-399,
- Abstract
- Full Text
- PDF
Assessing Risk for Ventricular Tachyarrhythmias and Sudden Cardiac Death: Is There a Role for Cardiac MRI? Circ Cardiovasc Imaging. 2012;5:2-5,
- Full Text
- PDF
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation. 2011;124:2761-2796,
- Full Text
- PDF